Sight Sciences Statistics
Total Valuation
Sight Sciences has a market cap or net worth of $424.18 million. The enterprise value is $386.40 million.
| Market Cap | 424.18M |
| Enterprise Value | 386.40M |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sight Sciences has 55.09 million shares outstanding. The number of shares has increased by 4.73% in one year.
| Current Share Class | 55.09M |
| Shares Outstanding | 55.09M |
| Shares Change (YoY) | +4.73% |
| Shares Change (QoQ) | +1.04% |
| Owned by Insiders (%) | 19.18% |
| Owned by Institutions (%) | 36.62% |
| Float | 35.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.09 |
| Forward PS | 4.43 |
| PB Ratio | 7.97 |
| P/TBV Ratio | 8.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.95, with a Debt / Equity ratio of 0.79.
| Current Ratio | 4.95 |
| Quick Ratio | 4.45 |
| Debt / Equity | 0.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.41 |
Financial Efficiency
Return on equity (ROE) is -48.42% and return on invested capital (ROIC) is -11.97%.
| Return on Equity (ROE) | -48.42% |
| Return on Assets (ROA) | -10.84% |
| Return on Invested Capital (ROIC) | -11.97% |
| Return on Capital Employed (ROCE) | -33.04% |
| Weighted Average Cost of Capital (WACC) | 16.86% |
| Revenue Per Employee | $448,263 |
| Profits Per Employee | -$159,984 |
| Employee Count | 186 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.69 |
Taxes
| Income Tax | -31,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +81.60% in the last 52 weeks. The beta is 2.42, so Sight Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.42 |
| 52-Week Price Change | +81.60% |
| 50-Day Moving Average | 5.27 |
| 200-Day Moving Average | 5.61 |
| Relative Strength Index (RSI) | 82.25 |
| Average Volume (20 Days) | 239,864 |
Short Selling Information
The latest short interest is 829,847, so 1.51% of the outstanding shares have been sold short.
| Short Interest | 829,847 |
| Short Previous Month | 726,624 |
| Short % of Shares Out | 1.51% |
| Short % of Float | 2.37% |
| Short Ratio (days to cover) | 4.02 |
Income Statement
In the last 12 months, Sight Sciences had revenue of $83.38 million and -$29.76 million in losses. Loss per share was -$0.56.
| Revenue | 83.38M |
| Gross Profit | 73.34M |
| Operating Income | -19.67M |
| Pretax Income | -29.79M |
| Net Income | -29.76M |
| EBITDA | -27.47M |
| EBIT | -27.88M |
| Loss Per Share | -$0.56 |
Balance Sheet
The company has $79.75 million in cash and $41.97 million in debt, with a net cash position of $37.78 million or $0.69 per share.
| Cash & Cash Equivalents | 79.75M |
| Total Debt | 41.97M |
| Net Cash | 37.78M |
| Net Cash Per Share | $0.69 |
| Equity (Book Value) | 52.89M |
| Book Value Per Share | 0.97 |
| Working Capital | 80.94M |
Cash Flow
In the last 12 months, operating cash flow was -$23.24 million and capital expenditures -$93,000, giving a free cash flow of -$23.33 million.
| Operating Cash Flow | -23.24M |
| Capital Expenditures | -93,000 |
| Depreciation & Amortization | 410,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -23.33M |
| FCF Per Share | -$0.42 |
Margins
Gross margin is 87.96%, with operating and profit margins of -23.60% and -35.69%.
| Gross Margin | 87.96% |
| Operating Margin | -23.60% |
| Pretax Margin | -35.73% |
| Profit Margin | -35.69% |
| EBITDA Margin | -32.94% |
| EBIT Margin | -33.43% |
| FCF Margin | n/a |
Dividends & Yields
Sight Sciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.73% |
| Shareholder Yield | -4.73% |
| Earnings Yield | -7.02% |
| FCF Yield | -5.50% |
Analyst Forecast
The average price target for Sight Sciences is $8.60, which is 11.69% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.60 |
| Price Target Difference | 11.69% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 12.27% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sight Sciences has an Altman Z-Score of -1.19 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.19 |
| Piotroski F-Score | 4 |